L’Oreal Settles With FTC Over Gene-Related Anti-Aging Skin Care Claims
This article was originally published in The Tan Sheet
Executive Summary
A proposed consent agreement with FTC bars L’Oreal USA from claiming its Lancome and L’Oreal Paris skin-care products target users’ genes with anti-aging benefits. The settlement, subject to public comment and final FTC approval, follows a 2012 FDA warning that cited some of the same marketing claims.